AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Timing bond allocations can reduce risk and stabilize income in retirement. Learn indicators and phased approaches to use bonds effectively.
22,161 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
When a celebrity moment goes beyond fashion, it becomes a teachable moment for money. This piece breaks down the fina...
Amazon dethroned Walmart to take the No. 1 spot on the Fortune 500 as revenue surged in 2025. CFO Brian Olsavsky stee...
Gulf sovereign funds are expanding AI bets, backing SpaceX-linked ventures and major AI rounds, signaling a shift fro...
As U.S.–Iran tensions flare, energy prices surge and corporate boards adjust risk, liquidity and strategy in a newly ...
The U.S. intensified strikes on Iran for a ninth night as Tehran attacked Gulf allies, pushing oil prices higher and ...
A former Apple executive recalls a 15-year lunch routine with Steve Jobs that emphasized curiosity over being right, ...
Unverified social-media chatter claims Trump commented on the death of Ayatollah Ali Khamenei, setting off market jit...
Oil crosses the critical $100 threshold as geopolitical tensions mount, sending Dow futures lower and pushing househo...
The White House granted a brief window for buyers to acquire oil already en route from Russia, sparking a mixed marke...
As Berkshire Hathaway transitions from Buffett to Greg Abel, Abel makes a bold opening move. This piece explains the ...
Silicon valley's tech right is steering AI and crypto bets toward policy-friendly outcomes. Critics warn the approach...